Analysts downgrade Orthofix shares — 5 quick facts

Zacks analysts downgraded Orthofix shares from a “buy” rating to a “hold” rating, according to MidSouth News & Analysis.

Advertisement

Here are five quick facts:

 

1. On Dec. 7, the company shares reached $39.33, up 1.5 percent.

 

2. Orthofix has a 52-week high of $42.61.

 

3. The 52-week low is $28.05.

 

4. Orthofix has a 50-day moving average of $38.14 and a 200-day moving average of $35.66.

 

5. The market cap is nearly $743 million.

 

Learn more about the value of outsourcing revenue cycle management — Click here!

 

More articles on orthopedics:
Dr. Howard Marans and the cost for knee surgery — 5 things to know
Dr. William Oppenheim receives Lifetime Achievement Award — 6 quick facts
Drs. Josh Blomberg, Simon Lee & more — 15 orthopedic surgeons making headlines

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.